BiotechTube
Home/Korro Bio/Katharine Knobil
KK

Katharine Knobil

Director

Korro Bio

Therapeutic Areas

Metabolic DisordersNeurologyRare DiseasesHepatology

Korro Bio Pipeline

DrugIndicationPhase
KRRO-121Urea Cycle Disorders / Hepatic Encephalopathy (Hyperammonemia)Preclinical
GalNAc Program (SERPINA1 target)Alpha-1 Antitrypsin Deficiency (AATD)Discovery
AMPKγ1 / Longevity (Liver) ProgramMetabolic/Liver Function RestorationDiscovery
TDP-43 ProgramAmyotrophic Lateral Sclerosis (ALS)Discovery

Leadership Team at Korro Bio

RA
Ram Aiyar
Chief Executive Officer & President
LV
Loic Vincent
Chief Scientific Officer
MG
Monica Goldklang
Clinical Advisory Board
NG
Noel G. McElvaney
Clinical Advisory Board
PS
Pavel Strnad
Clinical Advisory Board
JT
Jeffrey Teckman
Clinical Advisory Board
AM
Alice M. Turner
Clinical Advisory Board
TC
Todd Chappell
Chief Operating Officer
JM
Jeffrey M. Cerio
SVP, General Counsel
SE
Stephanie Engels
Chief People Officer
View full Korro Bio profile